Hepatitis, Chronic: all 829 studies

Page 5 of 9. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.

• Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-relatedCompletedNCT03313154
• Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6CompletedNCT03303599
• A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B PatientsStatus unknownNCT03244085Phase 1
• Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.CompletedNCT03241641Phase 4
• Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, SenegalCompletedNCT03215732
• The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus InfectionStatus unknownNCT03214302Not applicable
• The Changes of Cytokines During Antiviral TherapyStatus unknownNCT03210506Not applicable
• The Changes of Treg Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03210493Not applicable
• The Changes of Plasmacytoid Dendritic Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03210467
• The Changes of CD8+T Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03209037Phase 4
• The Changes of CD4+T Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03209011Phase 4
• The Changes of Natural Killer Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03208998Phase 4
• The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAsCompletedNCT03188276Early Phase 1
• The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult VolunteersCompletedNCT03180333Phase 1
• The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult VolunteersCompletedNCT03173599Phase 1
• Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B PatientsTerminatedNCT03164889Not applicable
• Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus PatientsStatus unknownNCT03163849Phase 3
• Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis BCompletedNCT03109730Phase 1/2
• Ezetimibe for Patients With Chronic Hepatitis DStatus unknownNCT03099278Phase 2
• Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis PatientsStatus unknownNCT03067883Phase 2
• Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAsCompletedNCT03063723
• Off-therapy Response After Stopping Entecavir or TenofovirStatus unknownNCT03042481
• Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis CStatus unknownNCT03022006Phase 4
• Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B PatientsStatus unknownNCT03013556Phase 4
• Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus CarriersStatus unknownNCT02991638Phase 3
• Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor DetectionStatus unknownNCT02973646Phase 4
• Metformin Therapy in HCV InfectionCompletedNCT02972723Phase 4
• The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis BStatus unknownNCT02965859Phase 2
• Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.Status unknownNCT02950870Phase 4
• HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection PatientsStatus unknownNCT02908763Phase 4
• A Study in Healthy Volunteers and Patients With Chronic Hepatitis BCompletedNCT02908191Phase 1
• A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High RiskStatus unknownNCT02901418
• A Study to Evaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAsStatus unknownNCT02894918Phase 4
• The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAgStatus unknownNCT02893124Phase 4
• Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB InfectionStatus unknownNCT02886182
• Regression of Liver Fibrosis After Daclatasvir and Asunaprevir TreatmentStatus unknownNCT02865369
• The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).Active, not recruitingNCT02845401Not applicable
• The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02838810Phase 4
• A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) InfectionTerminatedNCT02826018Phase 1
• Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) AdultsStatus unknownNCT02822547Phase 4
• Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control TrialStatus unknownNCT02817685
• Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)WithdrawnNCT02806362Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 TabletStatus unknownNCT02805738Phase 3
• Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology ConsortiumCompletedNCT02799355
• Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside AnaloguesCompletedNCT02792088Phase 3
• Association of Vitamin D Binding Protein Polymorphisms With Response to HCV TherapyCompletedNCT02788682
• Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis BStatus unknownNCT02774837Phase 4
• DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus InfectionActive, not recruitingNCT02772003Phase 1
• The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02745704Phase 4
• Off Treatment Durability in Chronic Hepatitis B With Good Immune ControlCompletedNCT02738554Not applicable
• SR-BI and Antiviral Treatment Response in HCVCompletedNCT02714712
• A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)CompletedNCT02662712Phase 1
• A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHBStatus unknownNCT02615639Phase 1/2
• Bartonella in Liver Transplant PatientsCompletedNCT02595710
• Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC TherapyCompletedNCT02594293Phase 4
• Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir TherapyStatus unknownNCT02589652
• Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® TabletCompletedNCT02589457Phase 1
• Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B PatientsStatus unknownNCT02581033Not applicable
• Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)CompletedNCT02578693
• Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected PatientsCompletedNCT02576314Phase 3
• A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B PatientsCompletedNCT02569372Phase 1
• REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B InfectionCompletedNCT02565719Phase 2
• Neutrophil Function During Therapy With Protease Inhibitors in Chronic Hepatitis CCompletedNCT02545335
• Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis BCompletedNCT02533544
• Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis BStatus unknownNCT02532413Phase 4
• Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With BaracludeStatus unknownNCT02523547Phase 4
• Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus RibavirinCompletedNCT02508090
• Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected PatientsCompletedNCT02482077Phase 4
• Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis BStatus unknownNCT02463019Phase 4
• Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)CompletedNCT02439567Not applicable
• Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon TherapyStatus unknownNCT02412592
• The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor InjectionStatus unknownNCT02412319Phase 4
• Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV PatientsCompletedNCT02401737Phase 1
• Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B PatientsStatus unknownNCT02387684
• Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B PatientsCompletedNCT02387463
• A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4Status unknownNCT02371408Phase 2/3
• Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentStatus unknownNCT02368288Phase 4
• Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentStatus unknownNCT02365402Phase 4
• Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) AnaloguesStatus unknownNCT02362490Phase 4
• Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infectionCompletedNCT02355951Not applicable
• Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon TreatmentStatus unknownNCT02348502
• First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1CompletedNCT02339207Phase 1
• Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral AgentsStatus unknownNCT02337127Phase 4
• A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis BCompletedNCT02332473Phase 2
• Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis BStatus unknownNCT02287857Not applicable
• Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis BCompletedNCT02263755
• Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B InfectionTerminatedNCT02258581
• Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis CCompletedNCT02250001
• Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis BCompletedNCT02249988Phase 2/3
• Effect of Camel Milk on Chronic Hepatitis CCompletedNCT02216045Phase 2
• Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected SubjectsCompletedNCT02202473Phase 4
• Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver DiseasesStatus unknownNCT02171949Phase 2
• Observational Study on Patients With Chronic Hepatitis BStatus unknownNCT02167503
• A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis CNo longer availableNCT02161939
• Accuracy of RTE for Evaluating Hepatic Fibrosis in Chronic Hepatitis: a Prospective Multicenter StudyStatus unknownNCT02143180
• Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) InfectionStatus unknownNCT02126137Phase 1
• Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis CCompletedNCT02123212Not applicable
• Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B PatientsCompletedNCT02112799Phase 1
• Hepatitis C in Renal Transplant RecipientsStatus unknownNCT02108301Phase 4
• Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis CWithdrawnNCT02099604Phase 3

← Hepatitis, Chronic overview